pt. 1. Introduction: Epidemiology of obesity ; Epidemiology of obesity : a global burden for the new millennium -- pt. 2. Pathophysiology of obesity: Environmental estrogens, endocrine disruption, and obesity ; Cigarette smoking, inflammation, and obesity ; Disordered eating as a correlate in the development of obesity ; Role of neurotransmitters in obesity regulation ; Neurobiology of obesity ; Leptin as a vasoactive adipokine : link between metabolism and vasculature ; Overview of ghrelin, appetite, and energy balance ; Molecular genetics of obesity syndrome : role of DNA methylation -- pt. 3. Obesity and degenerative diseases: Oxidative stress status in humans with metabolic syndrome ; Obesity and type 2 diabetes ; Angiogenesis-targeted redox-based therapeutics ; Obesity as an occult risk factor for drug and chemical toxicities -- pt. 4. Novel concept in obesity drug development: Adipose drug targets for obesity treatment -- pt. 5. Safety of obesity drugs: Safety of obesity drugs --

1. Obesity -- Epidemiology
2. Obesity -- Pathophysiology
3. Electronic books.